共 50 条
- [41] PHASE-II EVALUATION OF IPROPLATIN IN PATIENTS WITH ADVANCED GASTRIC AND PANCREATIC-CANCER AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (06): : 524 - 527
- [42] PHASE-II EVALUATION OF ACLACINOMYIN-A (NSC-208734) IN ADENOCARCINOMA OF THE KIDNEY AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (05): : 527 - 528
- [45] PHASE-II TRIALS OF MAYTANSINE, LOW-DOSE CHLOROZOTOCIN, AND HIGH-DOSE CHLOROZOTOCIN AS SINGLE AGENTS AGAINST ADVANCED MEASURABLE ADENOCARCINOMA OF THE PANCREAS CANCER TREATMENT REPORTS, 1985, 69 (04): : 417 - 420
- [46] PHASE-II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS - CANCER OF THE BREAST CANCER CHEMOTHERAPY REPORTS, 1964, (40): : 43 - 43
- [47] PHASE-II STUDY OF CAMPTOTHECIN (NSC 100-880) IN GASTROINTESTINAL CANCER PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1971, 12 (NMAR): : 18 - +
- [49] PHASE-II STUDY OF MAYTANSINE AND CHLOROZOTOCIN IN PATIENTS WITH DISSEMINATED MALIGNANT-MELANOMA CANCER TREATMENT REPORTS, 1980, 64 (4-5): : 721 - 723
- [50] PHASE-II EVALUATION OF METOPRINE IN ADVANCED PANCREATIC ADENOCARCINOMA CANCER TREATMENT REPORTS, 1984, 68 (7-8): : 1053 - 1054